GF Healthcare plans to sell Sino Business Investment Development Limited for HKD 60,000.
Jinwei Medical (08143) announced that on September 20, 2024, the company intends to sell Sino to Lin Xuejiao.
GF HEALTHCARE (08143) announced that on September 20, 2024, the company intends to sell all issued shares of Sino Business Investment Development Limited to Lin Xuejiao for a price of 60,000 Hong Kong dollars. The group expects to generate unaudited revenue of approximately 10.4 million Hong Kong dollars from the sale.
It is reported that the selling group has mainly been engaged in providing comprehensive hospital services in China, and has been in a state of suspension since July 2022.
Related Articles
Consun Pharma (01681) spent HK$1.54 million on October 27 to repurchase 100,000 shares.
Xiamen Jihong Package Technology (02603): Bai Xueting was selected as a staff representative director.
NIU HOLDINGS (08619) grants 448.09 million stock options.
Consun Pharma (01681) spent HK$1.54 million on October 27 to repurchase 100,000 shares.
Xiamen Jihong Package Technology (02603): Bai Xueting was selected as a staff representative director.
NIU HOLDINGS (08619) grants 448.09 million stock options.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
